GLPwatch
Trials (2101)
Page 33 of 36.
- Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
- Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
- A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
- A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
- BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
- Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
- Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
- The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
- Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
- Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
- New Imaging Procedure for the Localisation of Insulinoma
- Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants
- Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
- Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
- Treatment of GLP-1 for Diabetic Bariatric Patients
- Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
- Oral Semaglutide in Patients With Alzheimer's Disease
- Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
- Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
- Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
- Brain Activation and Satiety in Children 2
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- Effect of Gelofusine on GLP1-receptor Imaging
- Incretin-based Drugs and the Risk of Heart Failure
- Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice
- Semaglutide in Auto-HSCT
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
- Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
- Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
- A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
- Individualized Obesity Pharmacotherapy
- Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
- GLP Analogs for Diabetes in Wolfram Syndrome Patients
- A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
- Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
- Semaglutide vs Dulaglutide on Epicardial Adipose Tissue
- A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
- An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
- Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
- Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
- Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
- A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
- NC Works4Health: Reducing Chronic Disease Risks in Socioeconomically Disadvantaged, Unemployed Populations
- Liraglutide in Newly Onset Type 1 Diabetes.
- A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
- Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
- 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
- Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes